FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040385598> ?p ?o ?g. }

• W2040385598 endingPage "978" @default.
• W2040385598 startingPage "978" @default.
• W2040385598 abstract "Data are sparse regarding the prevalence, incidence, and independent prognostic value of minor and/or major electrocardiographic (ECG) abnormalities in asymptomatic postmenopausal women. There is no information on the effect, if any, of hormonal treatment on the prognostic value of the ECG.To examine association of minor and major baseline and incident ECG abnormalities with long-term cardiovascular morbidity and mortality.Post-hoc analysis of the estrogen plus progestin component of the Women's Health Initiative study, a randomized controlled primary prevention trial of 14 749 postmenopausal asymptomatic women with intact uterus who received 1 daily tablet containing 0.625 mg of oral conjugated equine estrogen and 2.5 mg of medroxyprogesterone acetate or a matching placebo. Participants were enrolled from 1993 to 1998, and the estrogen plus progestin trial was stopped on July 7, 2002.The Novacode criteria were used to define minor, major, and incident ECG abnormalities. Cardiovascular end points included incident coronary heart disease (CHD) and cardiovascular disease (CVD) events.Among women with absent (n = 9744), minor (n = 4095), and major (n = 910) ECG abnormalities, there were 118, 91, and 37 incident CHD events, respectively. The incident annual CHD event rates per 10 000 women with absent, minor, or major ECG abnormalities were 21 (95% confidence interval [CI], 18-26), 40 (95% CI, 32-49), and 75 (95% CI, 54-104), respectively. After 3 years of follow-up, 5% of women who had normal ECG at baseline developed new ECG abnormalities with an annual CHD event rate of 85 (95% CI, 44-164) per 10 000 women. The adjusted hazard ratios for CHD events were 1.55 (95% CI, 1.14-2.11) for minor baseline, 3.01 (95% CI, 2.03-4.46) for major baseline, and 2.60 (95% CI, 1.08-6.27) for incident ECG abnormalities. There were no significant interactions between hormone treatment assignment and ECG abnormalities for risk prediction of cardiovascular end points. For prediction of CHD events, the addition of ECG findings to the Framingham risk score increased from 0.69 to 0.74 the area under the receiver operating characteristic curve. Similar findings were found for incident CVD events.Among asymptomatic postmenopausal women, clinically relevant baseline and incident ECG abnormalities are independently associated with increased risk of cardiovascular events and mortality, and the information is incremental to the established method of risk stratification.clinicaltrials.gov Identifier: NCT00000611." @default.
• W2040385598 created "2016-06-24" @default.
• W2040385598 creator A5005650203 @default.
• W2040385598 creator A5009986689 @default.
• W2040385598 creator A5017418373 @default.
• W2040385598 creator A5020337180 @default.
• W2040385598 creator A5087659816 @default.
• W2040385598 date "2007-03-07" @default.
• W2040385598 modified "2023-10-01" @default.
• W2040385598 title "Major and Minor ECG Abnormalities in Asymptomatic Women and Risk of Cardiovascular Events and Mortality" @default.
• W2040385598 cites W1593442063 @default.
• W2040385598 cites W1967668941 @default.
• W2040385598 cites W1968209787 @default.
• W2040385598 cites W1981922048 @default.
• W2040385598 cites W1997058408 @default.
• W2040385598 cites W1999188847 @default.
• W2040385598 cites W2005544506 @default.
• W2040385598 cites W2009669511 @default.
• W2040385598 cites W2015195838 @default.
• W2040385598 cites W2018668538 @default.
• W2040385598 cites W2031203816 @default.
• W2040385598 cites W2045187405 @default.
• W2040385598 cites W2049798493 @default.
• W2040385598 cites W2092873877 @default.
• W2040385598 cites W2102375183 @default.
• W2040385598 cites W2134399140 @default.
• W2040385598 cites W2149437716 @default.
• W2040385598 cites W2165884492 @default.
• W2040385598 cites W2290627980 @default.
• W2040385598 doi "https://doi.org/10.1001/jama.297.9.978" @default.
• W2040385598 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17341712" @default.
• W2040385598 hasPublicationYear "2007" @default.
• W2040385598 type Work @default.
• W2040385598 sameAs 2040385598 @default.
• W2040385598 citedByCount "130" @default.
• W2040385598 countsByYear W20403855982012 @default.
• W2040385598 countsByYear W20403855982013 @default.
• W2040385598 countsByYear W20403855982014 @default.
• W2040385598 countsByYear W20403855982015 @default.
• W2040385598 countsByYear W20403855982016 @default.
• W2040385598 countsByYear W20403855982017 @default.
• W2040385598 countsByYear W20403855982018 @default.
• W2040385598 countsByYear W20403855982019 @default.
• W2040385598 countsByYear W20403855982020 @default.
• W2040385598 countsByYear W20403855982021 @default.
• W2040385598 countsByYear W20403855982022 @default.
• W2040385598 countsByYear W20403855982023 @default.
• W2040385598 crossrefType "journal-article" @default.
• W2040385598 hasAuthorship W2040385598A5005650203 @default.
• W2040385598 hasAuthorship W2040385598A5009986689 @default.
• W2040385598 hasAuthorship W2040385598A5017418373 @default.
• W2040385598 hasAuthorship W2040385598A5020337180 @default.
• W2040385598 hasAuthorship W2040385598A5087659816 @default.
• W2040385598 hasConcept C126322002 @default.
• W2040385598 hasConcept C142724271 @default.
• W2040385598 hasConcept C164705383 @default.
• W2040385598 hasConcept C204787440 @default.
• W2040385598 hasConcept C27081682 @default.
• W2040385598 hasConcept C2776306185 @default.
• W2040385598 hasConcept C2776607906 @default.
• W2040385598 hasConcept C2777164284 @default.
• W2040385598 hasConcept C2777910003 @default.
• W2040385598 hasConcept C29456083 @default.
• W2040385598 hasConcept C44249647 @default.
• W2040385598 hasConcept C67761136 @default.
• W2040385598 hasConcept C71924100 @default.
• W2040385598 hasConcept C82789193 @default.
• W2040385598 hasConceptScore W2040385598C126322002 @default.
• W2040385598 hasConceptScore W2040385598C142724271 @default.
• W2040385598 hasConceptScore W2040385598C164705383 @default.
• W2040385598 hasConceptScore W2040385598C204787440 @default.
• W2040385598 hasConceptScore W2040385598C27081682 @default.
• W2040385598 hasConceptScore W2040385598C2776306185 @default.
• W2040385598 hasConceptScore W2040385598C2776607906 @default.
• W2040385598 hasConceptScore W2040385598C2777164284 @default.
• W2040385598 hasConceptScore W2040385598C2777910003 @default.
• W2040385598 hasConceptScore W2040385598C29456083 @default.
• W2040385598 hasConceptScore W2040385598C44249647 @default.
• W2040385598 hasConceptScore W2040385598C67761136 @default.
• W2040385598 hasConceptScore W2040385598C71924100 @default.
• W2040385598 hasConceptScore W2040385598C82789193 @default.
• W2040385598 hasIssue "9" @default.
• W2040385598 hasLocation W20403855981 @default.
• W2040385598 hasLocation W20403855982 @default.
• W2040385598 hasOpenAccess W2040385598 @default.
• W2040385598 hasPrimaryLocation W20403855981 @default.
• W2040385598 hasRelatedWork W1978732061 @default.
• W2040385598 hasRelatedWork W1979625320 @default.
• W2040385598 hasRelatedWork W2025275274 @default.
• W2040385598 hasRelatedWork W2045848177 @default.
• W2040385598 hasRelatedWork W2057340019 @default.
• W2040385598 hasRelatedWork W2074437974 @default.
• W2040385598 hasRelatedWork W2078746766 @default.
• W2040385598 hasRelatedWork W2082571940 @default.
• W2040385598 hasRelatedWork W2413595473 @default.
• W2040385598 hasRelatedWork W3036247787 @default.
• W2040385598 hasVolume "297" @default.
• W2040385598 isParatext "false" @default.

• next